@dansfera: This is the ultimate regulatory pressure test! 🤯 See what goes down at the End-of-Phase 2 meeting, the *real* moment of truth before an asset can even *think* about Phase 3 trials. The agency dives deep into the entire clinical study report and data package to decide: green light or immediate clinical hold? Spoiler: It's less about proving effectiveness and everything to do with nailing down safety alignment for the next big step. Talk about high-stakes decision-making! #FDA #ClinicalTrials #PharmaLife #EOP2 #DrugDevelopment